Chemical Engineering @ChemengFiles.Com

ERYtech Pharma has obtained authorization from Afssaps to open a pharmaceutical headquarters in Lyon.
The activity of this new headquarters will include the export of products made by hand in Europe.

The first manufacturing unit is designed in accordance with European Directives and the Food and Drug U.S. (FDA's) allows the production of clinical batches and allow the manufacture of commercial batches on an industrial scale.

ERYtech Pharma has obtained authorization from Afssaps to open a pharmaceutical headquarters in Lyon.
The activity of this new headquarters will include the export of products made by hand in Europe.

The first manufacturing unit is designed in accordance with European Directives and the Food and Drug U.S. (FDA's) allows the production of clinical batches and allow the manufacture of commercial batches on an industrial scale.

Elsevier has announced that it begins to provide consistent guidelines for their internal divisions of pharmaceutical services in reprints of products, collections of articles or advertising on behalf of pharmaceutical companies. This initiative follows the internal review began when the company experienced a series of publications produced in Australia between 2000 and 2005 that had the name "journal of" but that it lacked adequate sponsorship presentations and

Given the numbers identified in the series of Australasia, the company has acted to ensure that all of its pharmaceutical services division of the world continue the practice of patronage and have consistent standards for the products of several reprint articles. Although these divisions of pharmaceutical services frequently reprinted articles revised Elsevier, manage separate from the division that publishes the central collection of the company of major research publications.

Elsevier has announced that it begins to provide consistent guidelines for their internal divisions of pharmaceutical services in reprints of products, collections of articles or advertising on behalf of pharmaceutical companies. This initiative follows the internal review began when the company experienced a series of publications produced in Australia between 2000 and 2005 that had the name "journal of" but that it lacked adequate sponsorship presentations and

Given the numbers identified in the series of Australasia, the company has acted to ensure that all of its pharmaceutical services division of the world continue the practice of patronage and have consistent standards for the products of several reprint articles. Although these divisions of pharmaceutical services frequently reprinted articles revised Elsevier, manage separate from the division that publishes the central collection of the company of major research publications.

Royal Cosun and Avantium have announced the start of their collaboration. Companies join forces to develop a specific process for the production of a new generation of bioplastics and biofuels from certain organic waste streams. Avantium will develop these bioplastics and biofuels in the name of 'Furanics.

Within the collaboration, Cosun will focus on the selection, isolation and purification of suitable components from agricultural waste streams. Avantium will continue to focus on developing a production process and efficient chemical catalyst. The duration of the first phase of collaboration will be approximately two years. With positive results, the companies intend to scale production technology and deploy a commercial scale.

Royal Cosun and Avantium have announced the start of their collaboration. Companies join forces to develop a specific process for the production of a new generation of bioplastics and biofuels from certain organic waste streams. Avantium will develop these bioplastics and biofuels in the name of 'Furanics.

Within the collaboration, Cosun will focus on the selection, isolation and purification of suitable components from agricultural waste streams. Avantium will continue to focus on developing a production process and efficient chemical catalyst. The duration of the first phase of collaboration will be approximately two years. With positive results, the companies intend to scale production technology and deploy a commercial scale.